Fierce Pharma

Lilly rounds out quartet of new US plants with $3.5B injectable and device facility in Pa.

On Friday, Eli Lilly unveiled designs on a new, $3.5 billion manufacturing facility in Pennsylvania’s Lehigh Valley, rounding ...
Indianapolis Business Journal

Trump draws attention to Lilly’s massive building spree. Here’s what’s in the works.

Eli Lilly and Co. has announced $50 billion in U.S. expansion commitments since 2020, including numerous manufacturing plants ...

Did Lilly's $3.5 Billion Retatrutide Plant Just Recast Eli Lilly's (LLY) Obesity Investment Narrative?

Eli Lilly and Company recently announced plans to invest more than US$3.50 billion in a new Lehigh Valley, Pennsylvania manufacturing facility that will produce next-generation injectable weight-loss ...
NC Biotech

Apiject to open generic injectable drug manufacturing facility in Apex

Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...
Hoodline

Sacramento Drugmaker Grabs Control Of Natomas Injection Plant

North Natomas just handed over one of its key industrial addresses to its longtime tenant, as Nivagen Pharmaceuticals has bought the building it already occupies at 3900 Duckhorn Drive in Sacramento.